Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Nolwenn Amrani"'
Autor:
Philippe Halfon, Denis Ouzan, Hacène Khiri, Guillaume Pénaranda, Paul Castellani, Valerie Oulès, Asma Kahloun, Nolwenn Amrani, Lise Fanteria, Agnès Martineau, Lou Naldi, Marc Bourlière
Publikováno v:
PLoS ONE, Vol 7, Iss 3, p e33000 (2012)
BACKGROUND & AIMS:Point mutations in the coding region of the interleukin 28 gene (rs12979860) have recently been identified for predicting the outcome of treatment of hepatitis C virus infection. This polymorphism detection was based on whole blood
Externí odkaz:
https://doaj.org/article/4c7285d3a0a64df59029b9d5799da9ea
Autor:
Nolwenn Amrani, Philippe Halfon, Jean-Marc Sabatier, Jérôme Courcambeck, Régis Perbost, Besma Jouirou, G. Pèpe, Mourad Bouzidi, Patrice Cacoub
Publikováno v:
Antiviral Therapy. 11:847-856
Background/aims One of the main issues in the development of antiviral therapy is the emergence of drug-resistant viruses. In the case of hepatitis C virus (HCV), selection of drug-resistant mutants was evidenced by in vitro studies on protease inhib
Autor:
Lou Naldi, Lise Fanteria, Philippe Halfon, Agnes Martineau, Denis Ouzan, Valérie Oules, Hacène Khiri, Nolwenn Amrani, Asma Kahloun, Paul Castellani, Marc Bourlière, Guillaume Penaranda
Publikováno v:
PLoS ONE
PLoS ONE, Vol 7, Iss 3, p e33000 (2012)
PLoS ONE, Vol 7, Iss 3, p e33000 (2012)
Background & Aims Point mutations in the coding region of the interleukin 28 gene (rs12979860) have recently been identified for predicting the outcome of treatment of hepatitis C virus infection. This polymorphism detection was based on whole blood